Raymed Labs Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported net loss was INR 0.162 million compared to INR 0.163 million a year ago. Basic loss per share from continuing operations was INR 0.0379 compared to INR 0.0382 a year ago. Diluted loss per share from continuing operations was INR 0.0379 compared to INR 0.0382 a year ago.
For the nine months, net loss was INR 0.921 million compared to INR 0.376 million a year ago. Basic loss per share from continuing operations was INR 0.2156 compared to INR 0.088 a year ago. Diluted loss per share from continuing operations was INR 0.2156 compared to INR 0.088 a year ago.